Evaluation of Safety and Efficacy of Xeloda in Metastatic Colorectal Carcinoma
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2016
At a glance
- Drugs Capecitabine (Primary)
- Indications Colorectal cancer
- Focus Adverse reactions
- Acronyms AXIOM
- Sponsors Roche
- 18 Sep 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 May 2013 Planned End Date changed from 1 Jun 2013 to 1 Jul 2013 as reported by ClinicalTrials.gov.
- 03 Apr 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.